市場調査レポート

ラテンアメリカの顔用注射剤市場

Latin American Markets for Facial Injectables 2013

発行 Decision Resources Group - Medtech Solutions 商品コード 128518
出版日 ページ情報 英文
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.32円で換算しております。
Back to Top
ラテンアメリカの顔用注射剤市場 Latin American Markets for Facial Injectables 2013
出版日: 2013年07月01日 ページ情報: 英文
概要

ラテンアメリカでは以前より美的な意識に大きな価値を置く文化が存在していますが、近年の急速な経済成長に伴って、顔用注射剤市場も急速に成長しています。

当レポートでは、ラテンアメリカの顔用注射剤市場について分析し、ボツリヌス毒素、ヒアルロン酸皮膚注射、粒子・ポリマーフィラーなどのセグメント別の市場動向と予測(今後10年間分)、市場シェア・平均販売価格を含めた競合動向をまとめ、概略下記の構成で取り上げております。

エグゼクティブサマリー

第1章 各国の概要

  • アルゼンチン
    • 人口統計と経済
    • 医療制度
    • 規制環境
    • 製造・流通体制
  • ブラジル
    • 人口統計と経済
    • 医療制度
    • 規制環境
    • 製造・流通体制
  • コロンビア
    • 人口統計と経済
    • 医療制度
    • 規制環境
    • 製造・流通体制
  • メキシコ
    • 人口統計と経済
    • 医療制度
    • 規制環境
    • 製造・流通体制
  • ラテンアメリカの規制環境

第2章 臨床環境

  • 背景
  • 処置概要
  • 競合療法(全8種)
    • レーザー・リサーフェシング
    • 整形美顔術
    • ケミカルピール
    • 削皮術
    • コスメシューティカル
    • ニュートリコスメティクス
    • ニュートリゲノミクス
    • 新たな競合療法
  • ガイドラインと診断パターン

第3章 製品

  • ボツリヌス毒素
  • 皮膚充填剤
    • ヒアルロン酸充填剤
      • 標準型ヒアルロン酸充填剤
      • 回春用ヒアルロン酸充填剤
      • ボリュマイズ用ヒアルロン酸充填剤
    • その他
  • 多血小板血漿療法
  • ポリエチレングリコール

第4章 治験

  • 直接比較試験(Head-to-Head)
  • 皮膚充填剤の進歩
  • 併用療法
  • 新たな競合療法

第5章 顔面注射剤市場

  • 市場の現状
  • 市場の詳細分析
    • アルゼンチン
    • ブラジル
    • コロンビア
    • メキシコ
  • 競合状況
  • 詳細な競合環境
  • 市場シェア
  • 近年の動向
  • 最も有望な新規製品

第6章 ボツリヌス毒素市場

  • 市場の現状
  • 市場の詳細分析
  • 競合状況
  • 市場シェア

第7章 皮膚充填剤市場

  • 市場の現状
  • 市場の詳細分析
    • 素材別
      • ヒアルロン酸充填剤
      • その他の充填剤
    • 国別
      • アルゼンチン
      • ブラジル
      • コロンビア
      • メキシコ
  • 競合状況
  • 市場シェア

付録:分析手法

付録:略語・頭語集

付録:関連調査

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: RPLA41FA13

The Latin America markets for facial injectables will expand at a rapid pace, due in part to a culture that places great value on aesthetic consciousness, combined with burgeoning economies in some of the countries.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for facial injectables in Latin America across a 10-year period.

Questions Answered in This Report:

  • The Latin America facial injectable market will grow over the forecast period.
    • Which segment will see strongest growth?
    • What trends are fueling faster growth in some countries and slower expansion in others?
  • The Latin America facial injectable competitive landscape consists of both large international companies as well as domestic manufacturers.
    • What types of strategies are these two types of competitors employing to gain market share?
    • What factors will contribute to the success of competitors in the Latin America facial injectable market?
    • Which companies are the largest competitors in the market within each country and in the overall Latin America region?
  • Illegally manufactured and counterfeit products are prevalent in the Latin American region.
  • How has the availability of these unapproved products affected the market?

Scope:

Geographies Covered: Argentina, Brazil, Colombia, Mexico

Procedures and Products Covered: Millennium Research Group's analysis uses the following breakdown of procedures and products:

*Other dermal fillers include semipermanent and nonpermanent dermal fillers. Newer-generation PRP and collagen fillers are not included in market valuations because these new products have yet to make a substantial impact on the market.

Market Forecast Features: Based on primary research with industry professionals, Millennium Research Group uses its proprietary forecasting model to provide an in-depth examination of current and future trends in procedure volumes, unit sales, ASPs, and market values over a 10-year period (2011-2021).

Competitive Analysis: Millennium Research Group provides a detailed analysis of the competitive landscape and market shares for leading competitors.

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES AND TABLES

EXECUTIVE SUMMARY

1. COUNTRY OVERVIEWS

  • 1.1. Argentina
    • 1.1.1. Demographics and Economy
    • 1.1.2. Health Care System
    • 1.1.3. Regulatory Environment
    • 1.1.4. Manufacturing and Distribution
  • 1.2. Brazil
    • 1.2.1. Demographics and Economy
    • 1.2.2. Health Care System
    • 1.2.3. Regulatory Environment
    • 1.2.4. Manufacturing and Distribution
  • 1.3. Colombia
    • 1.3.1. Demographics and Economy
    • 1.3.2. Health Care System
    • 1.3.3. Regulatory Environment
    • 1.3.4. Manufacturing and Distribution
  • 1.4. Mexico
    • 1.4.1. Demographics and Economy
    • 1.4.2. Health Care System
    • 1.4.3. Regulatory Environment
    • 1.4.4. Manufacturing and Distribution
  • 1.5. Latin American Regulatory Environment

2. CLINICAL LANDSCAPE

  • 2.1. Background
  • 2.2. Procedure Descriptions
  • 2.3. Competing Treatments
    • 2.3.1. Laser Resurfacing
    • 2.3.2. Facial Lifts
    • 2.3.3. Chemical Peels
    • 2.3.4. Dermabrasion
    • 2.3.5. Cosmeceuticals
    • 2.3.6. Nutricosmetics
    • 2.3.7. Nutrigenomics
    • 2.3.8. Emerging Competing Treatments
  • 2.4. Guidelines and Diagnosis Patterns

3. PRODUCTS

  • 3.1. Botulinum Toxins
  • 3.2. Dermal Fillers
    • 3.2.1. Hyaluronic Acid Fillers
      • 3.2.1.1. Standard Hyaluronic Acid Dermal Fillers
      • 3.2.1.2. Rejuvenation Hyaluronic Acid Dermal Fillers
      • 3.2.1.3. Volumizing Hyaluronic Acid Dermal Fillers
    • 3.2.2. Other Dermal Fillers
  • 3.3. Platelet-Rich Plasma Therapy
  • 3.4. Polyethylene Glycol

4. CLINICAL TRIALS

  • 4.1. Head-to-Head
  • 4.2. Advancements in Dermal Fillers
  • 4.3. Combination Treatments
  • 4.4. Emerging Competing Treatments

5. FACIAL INJECTABLE MARKET

  • 5.1. Market Snapshot
  • 5.2. Detailed Market Analysis
    • 5.2.1. Argentina
    • 5.2.2. Brazil
    • 5.2.3. Colombia
    • 5.2.4. Mexico
  • 5.3. Competitive Snapshot
  • 5.4. Detailed Competitive Landscape
  • 5.5. Market Shares
  • 5.6. Recent Events
  • 5.7. Most Promising Emerging Products

6. BOTULINUM TOXIN MARKET

  • 6.1. Market Snapshot
  • 6.2. Detailed Market Analysis
  • 6.3. Competitive Snapshot
  • 6.4. Market Shares

7. DERMAL FILLER MARKET

  • 7.1. Market Snapshot
  • 7.2. Detailed Market Analysis
    • 7.2.1. By Material
      • 7.2.1.1. Hyaluronic Acid Dermal Fillers
      • 7.2.1.2. Other Dermal Fillers
    • 7.2.2. By Country
      • 7.2.2.1. Argentina
      • 7.2.2.2. Brazil
      • 7.2.2.3. Colombia
      • 7.2.2.4. Mexico
  • 7.3. Competitive Snapshot
  • 7.4. Market Shares

APPENDIX: METHODOLOGY

APPENDIX: ACRONYMS AND INITIALISMS

APPENDIX: BIBLIOGRAPHY

LIST OF FIGURES AND TABLES

TABLE OF CONTENTS

LIST OF FIGURES AND TABLES

EXECUTIVE SUMMARY

  • Figure 1: Facial Injectable Market, by Country, Latin America (USD), 2011-2021
  • Table 1: Facial Injectable Market Landscape, Latin America (USD), 2012 and 2021
  • Table 2: Facial Injectable Market Leaders, by Product Type and Revenue, Latin America, 2012
  • Table 3: Companies Mentioned
  • Table 4: Factors Impacting the Facial Injectable Market, by Product Type, Latin America
  • Table 5: Recent Novel Devices in the Facial Injectable Market, by Product Type, Latin America, 2012
  • Table 6: Expected Key Events in the Facial Injectable Market, Latin America
  • Table 7: Key Report Updates
  • Table 8: Geographies Covered, Latin America
  • Table 9: Average Currency Exchange Rates
  • Table 10: Facial Injectable Procedures and Products Covered, Latin America
  • Table 11: Common Facial Injectable Brands

1. COUNTRY OVERVIEWS

  • Table 12: Key Health and Economic Indicators, Argentina
  • Table 13: Key Health and Economic Indicators, Brazil
  • Table 14: Key Health and Economic Indicators, Colombia
  • Table 15: Key Health and Economic Indicators, Mexico

2. CLINICAL LANDSCAPE

  • Table 16: Areas of the Face Commonly Treated with Facial Injectables
  • Table 17: Common Facial Injectable Indications, by Product Type
  • Table 18: Facial Injectable Treatment Guidelines, by Product Type

3. PRODUCTS

  • Table 19: Advantages and Disadvantages of Facial Injectables, by Product Type
  • Table 20: BTX-A and BTX-B Functions
  • Table 21: Dermal Filler Functions, by Material and Product Feature
  • Table 22: Advantages and Disadvantages of Dermal Fillers, by Material and Product Feature

4. CLINICAL TRIALS

  • Table 23: Head2Head
  • Table 24: Safety and Efficacy of Two Types of Botulinum Toxin Type A for the Treatment of Glabellar Lines
  • Table 25: Safety and Effectiveness of Aquamid as Compared to Restylane for the Aesthetic Treatment
  • Table 26: EMERVEL Classic Lidocaine Versus JUVÉDERM Ultra in Treatment of Moderate to Severe Facial Wrinkles and Folds
  • Table 27: Efficacy and Safety Study of Botulinum Toxin Type A to Treat Glabellar Lines
  • Table 28: Safety and Efficacy Study of Botulinum Toxin Type A to Treat Glabellar Lines
  • Table 29: Efficacy and Safety Study of Neuramis in Correction of Nasolabial Fold
  • Table 30: Efficacy and Safety of DWP450 Compared With Botox in Moderate to Severe Glabellar Line
  • Table 31: Safety and Efficacy of JUVÉDERM Injectable Gel with Lidocaine
  • Table 32: Post-Market Study of JUVÉDERM VOLIFT With Lidocaine for the Correction of Nasolabial Folds
  • Table 33: Volume Restoration of the Aging Midface with Sculptra Aesthetic
  • Table 34: Use Of Three Commercial Preparations Of Injectable Hyaluronic Acid In Hands Rejuvenation
  • Table 35: Study for the Evaluation of the Efficacy and Safety of the Dermal Filler Princess VOLUME in Nasolabial Folds
  • Table 36: JUVÉDERM VOLUMA to Enhance the Appearance of the Asian Nose
  • Table 37: JUVE_BTX
  • Table 38: FIRST
  • Table 39: Lateral Canthal Rhytides With Medium Depth Chemical Peel With or Without Pretreatment With Botulinum Toxin A
  • Table 40: RADIANT
  • Table 41: Open Label Study to Assess Long-term Safety of Repeat Administration of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines
  • Table 42: Solid State Hyaluronic Acid: A Novel Delivery System to Enable the Precise and Rapid Treatment of Fine and Deep Wrinkles

5. FACIAL INJECTABLE MARKET

  • Figure 2: Facial Injectable Market, by Country, Latin America (USD), 2011-2021
  • Figure 3: Facial Injectable Market, by Product Type, Latin America (USD), 2011-2021
  • Table 43: Factors Impacting the Facial Injectable Market, by Product Type, Latin America
  • Table 44: Volume of Facial Injectable Product per Procedure, by Product Type
  • Table 45: Facial Injectable Procedures, by Product Type, Latin America, 2011-2021
  • Table 46: Facial Injectable Procedures, by Country, Latin America, 2011-2021
  • Table 47: Facial Injectable Market, by Product Type, Latin America (USD), 2011-2021
  • Table 48: Facial Injectable Market Growth, by Product Type, Latin America, 2012-2021
  • Table 49: Facial Injectable Market, by Product Type, as a % of Total, Latin America, 2011-2021
  • Table 50: Facial Injectable Market, by Country, Latin America (USD), 2011-2021
  • Table 51: Facial Injectable Market Growth, by Country, Latin America, 2012-2021
  • Table 52: Facial Injectable Market, by Country, as a % of Total, Latin America, 2011-2021
  • Table 53: Facial Injectable Procedures, by Product Type, Argentina, 2011-2021
  • Table 54: Facial Injectable Market, by Product Type, Argentina (USD), 2011-2021
  • Table 55: Facial Injectable Market, by Product Type, Argentina (ARS), 2011-2021
  • Table 56: Facial Injectable Market Growth, by Product Type, Argentina, 2012-2021
  • Table 57: Facial Injectable Market, by Product Type, as a % of Total, Argentina, 2011-2021
  • Table 58: Facial Injectable Procedures, by Product Type, Brazil, 2011-2021
  • Table 59: Facial Injectable Market, by Product Type, Brazil (USD), 2011-2021
  • Table 60: Facial Injectable Market, by Product Type, Brazil (BRL), 2011-2021
  • Table 61: Facial Injectable Market Growth, by Product Type, Brazil, 2012-2021
  • Table 62: Facial Injectable Market, by Product Type, as a % of Total, Brazil, 2011-2021
  • Table 63: Facial Injectable Procedures, by Product Type, Colombia, 2011-2021
  • Table 64: Facial Injectable Market, by Product Type, Colombia (USD), 2011-2021
  • Table 65: Facial Injectable Market, by Product Type, Colombia (COP), 2011-2021
  • Table 66: Facial Injectable Market Growth, by Product Type, Colombia, 2012-2021
  • Table 67: Facial Injectable Market, by Product Type, as a % of Total, Colombia, 2011-2021
  • Table 68: Facial Injectable Procedures, by Product Type, Mexico, 2011-2021
  • Table 69: Facial Injectable Market, by Product Type, Mexico (USD), 2011-2021
  • Table 70: Facial Injectable Market, by Product Type, Mexico (MXN), 2011-2021
  • Table 71: Facial Injectable Market Growth, by Product Type, Mexico, 2012-2021
  • Table 72: Facial Injectable Market, by Product Type, as a % of Total, Mexico, 2011-2021
  • Figure 4: Leading Competitors in the Facial Injectable Market, as a % of Total, Latin America, 2012
  • Table 73: Leading Competitors in the Facial Injectable Market, by Product Type, as a % of Total, Latin America, 2012
  • Table 74: Leading Competitors in the Facial Injectable Market, by Country, as a % of Total, Latin America, 2012
  • Table 75: Recent Events in the Facial Injectable Market, Latin America
  • Table 76: Emerging Products in Development for the Facial Injectable Market, Latin America

6. BOTULINUM TOXIN MARKET

  • Figure 5: BTX Market, by Country, Latin America (USD), 2011-2021
  • Table 77: BTX Procedures, by Country, Latin America, 2011-2021
  • Table 78: BTX Market, by Country, Latin America (USD), 2011-2021
  • Table 79: BTX Market Growth, by Country, Latin America, 2012-2021
  • Table 80: BTX Market, by Country, as a % of Total, Latin America, 2011-2021
  • Table 81: BTX Market, Argentina (USD and ARS), 2011-2021
  • Table 82: BTX Market, Brazil (USD and BRL), 2011-2021
  • Table 83: BTX Market, Colombia (USD and COP), 2011-2021
  • Table 84: BTX Market, Mexico (USD and MXN), 2011-2021
  • Figure 6: Leading Competitors in the BTX Market, as a % of Total, Latin America, 2012
  • Table 85: Leading Competitors in the BTX Market, by Country, as a % of Total, Latin America, 2012

7. DERMAL FILLER MARKET

  • Figure 7: Dermal Filler Market, by Country, Latin America (USD), 2011-2021
  • Figure 8: Dermal Filler Market, by Material, Latin America (USD), 2011-2021
  • Table 86: Dermal Filler Procedures, by Material, Latin America, 2011-2021
  • Table 87: Dermal Filler Market, by Material, Latin America (USD), 2011-2021
  • Table 88: Dermal Filler Market Growth, by Material, Latin America, 2012-2021
  • Table 89: Dermal Filler Market, by Material, as a % of Total, Latin America, 2011-2021
  • Table 90: HA Dermal Filler Procedures, by Country, Latin America, 2011-2021
  • Table 91: HA Dermal Filler Market, by Country, Latin America (USD), 2011-2021
  • Table 92: HA Dermal Filler Market Growth, by Country, Latin America, 2012-2021
  • Table 93: HA Dermal Filler Market, by Country, as a % of Total, Latin America, 2011-2021
  • Table 94: Other Dermal Filler Procedures, by Country, Latin America, 2011-2021
  • Table 95: Other Dermal Filler Market, by Country, Latin America (USD), 2011-2021
  • Table 96: Other Dermal Filler Market Growth, by Country, Latin America, 2012-2021
  • Table 97: Other Dermal Filler Market, by Country, as a % of Total, Latin America, 2011-2021
  • Table 98: Dermal Filler Procedures, by Country, Latin America, 2011-2021
  • Table 99: Dermal Filler Market, by Country, Latin America (USD), 2011-2021
  • Table 100: Dermal Filler Market Growth, by Country, Latin America, 2012-2021
  • Table 101: Dermal Filler Market, by Country, as a % of Total, Latin America, 2011-2021
  • Table 102: Dermal Filler Procedures, by Material, Argentina, 2011-2021
  • Table 103: Dermal Filler Market, by Material, Argentina (USD), 2011-2021
  • Table 104: Dermal Filler Market, by Material, Argentina (ARS), 2011-2021
  • Table 105: Dermal Filler Market Growth, by Material, Argentina, 2012-2021
  • Table 106: Dermal Filler Market, by Material, as a % of Total, Argentina, 2011-2021
  • Table 107: Dermal Filler Procedures, by Material, Brazil, 2011-2021
  • Table 108: Dermal Filler Market, by Material, Brazil (USD), 2011-2021
  • Table 109: Dermal Filler Market, by Material, Brazil (BRL), 2011-2021
  • Table 110: Dermal Filler Market Growth, by Material, Brazil, 2012-2021
  • Table 111: Dermal Filler Market, by Material, as a % of Total, Brazil, 2011-2021
  • Table 112: Dermal Filler Procedures, by Material, Colombia, 2011-2021
  • Table 113: Dermal Filler Market, by Material, Colombia (USD), 2011-2021
  • Table 114: Dermal Filler Market, by Material, Colombia (COP), 2011-2021
  • Table 115: Dermal Filler Market Growth, by Material, Colombia, 2012-2021
  • Table 116: Dermal Filler Market, by Material, as a % of Total, Colombia, 2011-2021
  • Table 117: Dermal Filler Procedures, by Material, Mexico, 2011-2021
  • Table 118: Dermal Filler Market, by Material, Mexico (USD), 2011-2021
  • Table 119: Dermal Filler Market, by Material, Mexico (MXN), 2011-2021
  • Table 120: Dermal Filler Market Growth, by Material, Mexico, 2012-2021
  • Table 121: Dermal Filler Market, by Material, as a % of Total, Mexico, 2011-2021
  • Figure 9: Leading Competitors in the Dermal Filler Market, as a % of Total, Latin America, 2012
  • Table 122: Leading Competitors in the Dermal Filler Market, by Material, as a % of Total, Latin America, 2012
  • Table 123: Leading Competitors in the Dermal Filler Market, by Country, as a % of Total, Latin America, 2012
  • Table 124: Leading Competitors in the HA Dermal Filler Market, by Country, as a % of Total, Latin America, 2012
  • Table 125: Leading Competitors in the Other Dermal Filler Market, by Country, as a % of Total, Latin America, 2012

APPENDIX: METHODOLOGY

APPENDIX: ACRONYMS AND INITIALISMS

  • Table 126: Acronyms and Initialisms

APPENDIX: BIBLIOGRAPHY

Back to Top